Order Article Reprints

Ferrante M, Furlan D, Zibellini S, Borriero M, Candido C, Sahnane N, Uccella S, Genuardi E, Alessandria B, Bianchi B, et al. MYD88^L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation. Diagnostics. 2021; 11(5):779. https://doi.org/10.3390/diagnostics11050779

Ferrante, Martina, Daniela Furlan, Silvia Zibellini, Michela Borriero, Chiara Candido, Nora Sahnane, Silvia Uccella, Elisa Genuardi, Beatrice Alessandria, Benedetta Bianchi, and et al. 2021. "MYD88^L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation" Diagnostics 11, no. 5: 779. https://doi.org/10.3390/diagnostics11050779

Ferrante, M., Furlan, D., Zibellini, S., Borriero, M., Candido, C., Sahnane, N., Uccella, S., Genuardi, E., Alessandria, B., Bianchi, B., Mora, B., Grimaldi, D., Defrancesco, I., Jiménez, C., Cavallo, F., Ferrero, D., Dogliotti, I., Merli, M., Varettoni, M., ... Drandi, D. (2021). MYD88^L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation. Diagnostics, 11(5), 779. https://doi.org/10.3390/diagnostics11050779